JG
CRBP icon

Jain Global’s Corbus Pharmaceuticals CRBP Stock Holding History

Jain Global’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,369
Closed -$85.3K – 1104
2025
Q2 		$85.3K Buy
+12,369
New +$89.9K ﹤0.01% 1050
2025
Q1 		– Sell
-15,426
Closed -$182K – 1122
2024
Q4 		$182K Buy
+15,426
New +$259K 0.01% 651

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Jain Global's CRBP Position: Q3 2025 in Review

Jain Global sold out of Corbus Pharmaceuticals (CRBP) in Q3 2025, closing a stake of 12,369 shares — an estimated $85.3K sold.

Jain Global first reported a position in CRBP in Q4 2024 and held it in 2 quarters. The position peaked at $182K in Q4 2024. 81 funds tracked by Wall St. Rank hold CRBP as of Q3 2025.

  • Jain Global reported no remaining Corbus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Jain Global sold 12,369 Corbus Pharmaceuticals shares in Q3 2025, an estimated $85.3K.
  • Jain Global first reported a position in Corbus Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Jain Global's Corbus Pharmaceuticals position peaked at $182K in Q4 2024.
  • 81 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.